> Mein DÄ

PHARMA

Valproinsäure: Was bei der Migräneprophylaxe zu beachten ist

Dtsch Arztebl 2011; 108(8): A-406 / B-330 / C-330

Diener, Hans-Christoph

1.	Diener H, Fritsche G, Obermann M, Limmroth V, May A, Pfaffenrath V, et al.: Therapie der Migräne. In: Diener H, Putzki N, Berlit P, Deuschl G, Elger C, Gold R et al.: Leitlinien für Diagnostik und Therapie in der Neurologie. 4. Auflage ed. Stuttgart: Thieme 2008: 579–95.
2.	Freitag F, Collins S, Carlson H, Goldstein J, Saper J, Silberstein S et al.: A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology 2002; 58: 1652–9. MEDLINE
3.	Klapper J, an behalf of the Divalproex Sodium in Migraine Prophylaxis Study Group. Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia 1997; 17(2): 103–8. MEDLINE
4.	Hering R, Kurzitzky A: Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia 1992; 12: 81–4. MEDLINE
5.	Kaniecki RG: A comparision of divalproex with propranolol and placebo for the prophylaxis of migraine without aura. Arch Neurol 1997; 54: 1141–5. MEDLINE
6.	Jensen R, Brinck T, Olesen J: Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology 1994; 44: 647–51. MEDLINE
7.	Silberstein SD, Collins SD, Carlson H, The Depakote ER Migraine Stuyd Group: Safety and efficacy of once-daily, extended-release divalproex sodium monotherapy for the prophylaxis of migraine headaches. Cephalalgia 2000; 20: 269. MEDLINE
8.	Mathew NT, Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S et al.: Migraine prophylaxis with divalproex. Arch Neurol 1995; 52: 281–6. MEDLINE
9.	Mulleners VVM, Chronicle EP: Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia 2008; 28(6): 585–97. MEDLINE
10.	Apostol G, Pakalnis A, Laforet GA, Robieson VVZ, Olson E, Abi-Saab WM et al.: Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an open-labet extension trial in adolescents. Headache 2009; 149(1): 36–44. MEDLINE
11.	Apostol G, Lewis DW, Laforet GA, Robieson WZ, Fugate JM, Abi-Saab WM et al.: Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-labe) safety study. Headache 2009; 149(1): 45–53. MEDLINE
12.	Apostol G, Cady RK, Laforet GA, Robieson WZ, Olson E, Abi-Saab WM et al.: Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study. Headache 2008; 48(7): 1012–25. MEDLINE

Zum Artikel

Login

Passwort vergessen?

Registrieren

Eingeloggt als $LOGINEMAIL$